{
    "clinical_study": {
        "@rank": "67098", 
        "arm_group": [
            {
                "arm_group_label": "Patient-centred tailored intervention", 
                "arm_group_type": "Experimental", 
                "description": "Medicines Advice Service"
            }, 
            {
                "arm_group_label": "Control", 
                "arm_group_type": "No Intervention", 
                "description": "Usual care"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to find out whether talking to a pharmacist on the telephone\n      can help to support people taking medicine for a long-term condition."
        }, 
        "brief_title": "The Medicines Advice Service Evaluation", 
        "condition": [
            "Type 2 Diabetes", 
            "Hyperlipidemias"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Diabetes Mellitus, Type 2", 
                "Hyperlipidemias"
            ]
        }, 
        "detailed_description": {
            "textblock": "Non-adherence to medication is common and although some interventions have shown promise in\n      improving adherence, the findings are inconsistent. This randomised controlled trial aims to\n      test the effectiveness of a pharmacy-based telephone intervention compared to usual care on\n      medication adherence and health outcomes in patients taking medicines for a long-term\n      condition."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients prescribed medication(s) for at least one of the following conditions: type\n             2 diabetes, hyperlipidemia\n\n        Exclusion Criteria:\n\n          -  Patients living outside of England\n\n          -  Patients with no access to a telephone\n\n          -  Patients under the age of 18\n\n          -  Patients unable to give written informed consent\n\n          -  Patients on drugs for dementia\n\n          -  Patients showing signs of dementia or cognitive impairment in conversation\n\n          -  Patients with substantial hearing or sight impairment\n\n          -  Patients whose medications are ordered by a caregiver/family member\n\n          -  Patients with insufficient English to take part in the telephone intervention\n\n          -  Patients living with someone already taking part in the study\n\n          -  Patients newly prescribed a medication for the conditions listed in the inclusion\n             criteria"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "600", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 29, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01864239", 
            "org_study_id": "12/0326"
        }, 
        "intervention": {
            "arm_group_label": "Patient-centred tailored intervention", 
            "description": "The intervention consists of:\nTelephone consultations with a pharmacist\nFollow-up tailored written information\nA medicine reminder chart", 
            "intervention_name": "Medicines Advice Service", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "Adherence", 
        "lastchanged_date": "May 23, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "London", 
                    "country": "United Kingdom"
                }, 
                "name": "UCL School of Pharmacy"
            }
        }, 
        "location_countries": {
            "country": "United Kingdom"
        }, 
        "number_of_arms": "2", 
        "official_title": "The Medicines Advice Service: A Randomised Controlled Trial of a Pharmacy-based Telephone Intervention to Support Patients Taking Medication for a Long-term Condition", 
        "overall_official": {
            "affiliation": "UCL School of Pharmacy", 
            "last_name": "Nick Barber", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Enrolling by invitation", 
        "oversight_info": {
            "authority": "United Kingdom: Research Ethics Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "February 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Self-reported medication adherence", 
            "safety_issue": "No", 
            "time_frame": "6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01864239"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Prescription refill adherence", 
                "safety_issue": "No", 
                "time_frame": "Baseline, 6 months and 12 months"
            }, 
            {
                "description": "Medicine-related problems and concerns will be assessed in a self-report questionnaire.", 
                "measure": "Self-reported medicine-related problems and concerns", 
                "safety_issue": "No", 
                "time_frame": "Baseline, 3 months and 6 months"
            }, 
            {
                "description": "Beliefs about medicines will be assessed in a self-report questionnaire using the Beliefs About Medicines Questionnaire (BMQ) (Horne et al. 1999).", 
                "measure": "Beliefs about Medicines", 
                "safety_issue": "No", 
                "time_frame": "Baseline, 3 months and 6 months"
            }, 
            {
                "measure": "HbA1c", 
                "safety_issue": "No", 
                "time_frame": "Baseline and 6 months"
            }, 
            {
                "measure": "Serum Cholesterol Levels", 
                "safety_issue": "No", 
                "time_frame": "Baseline and 6 months"
            }
        ], 
        "source": "University College, London", 
        "sponsors": {
            "collaborator": {
                "agency": "Pharmacy2U", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "University College, London", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care", 
        "study_type": "Interventional", 
        "verification_date": "April 2013"
    }
}